Senior Advisor

Jack E. Henningfield, Ph.D.
Associate Professor
Johns Hopkins School of Medicine
Vice President, Research and Health Policy
Pinney Associates
4800 Montgomery Lane, Suite 1000
Bethesda, MD 20814-3433
Phone: 301-718-8440
Fax: 301-718-0034
Email: jhenning@pinneyassociates.com

Jack E. Henningfield, Ph.D., is Professor (Adjunct) Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, where directs the Robert Wood Johnson Foundation’s Innovators Combating Substance Abuse Awards Program.  He is also Vice President for Research and Health Policy at Pinney Associates, which is a public health issues consulting group in Bethesda, Maryland.  Dr. Henningfield was formerly chief of the Clinical Pharmacology Branch and the Biology of Dependence and Abuse Liability Assessment Laboratory of the National Institute on Drug Abuse (NIDA).  While at NIDA, he frequently served as liaison to the Food and Drug Administration, Centers for Disease Control, Department of Defense, and other agencies concerning tobacco and other drug-related issues. The discovery process of his laboratory focused on furthering the understanding of the biology of addiction to provide the foundation for more effective treatment and prevention.  His more than 350 publications include studies of alcohol, marijuana, nicotine, opioids, sedatives, and stimulants as well as reviews, books, and drug control policy articles.  He was co-editor of the Surgeon General’s Report, Nicotine Addiction (1988), and has contributed to numerous other Surgeon General’s Reports on Smoking and Health, and monographs from the National Cancer Institute and National Institute on Drug Abuse, as well as reports by other national and international health organizations.  He presently serves on the World Health Organization Study Group on Tobacco Regulation (WHO TobReg). He has testified on behalf of plaintiffs against the tobacco industry.  His current activities focus on the intersection of science, public health, and policy, as related to tobacco, prescription drugs, and illicit drugs of abuse.